170 related articles for article (PubMed ID: 35192693)
21. Chromothripsis Is a Recurrent Genomic Abnormality in High-Risk Myelodysplastic Syndromes.
Abáigar M; Robledo C; Benito R; Ramos F; Díez-Campelo M; Hermosín L; Sánchez-Del-Real J; Alonso JM; Cuello R; Megido M; Rodríguez JN; Martín-Núñez G; Aguilar C; Vargas M; Martín AA; García JL; Kohlmann A; Del Cañizo MC; Hernández-Rivas JM
PLoS One; 2016; 11(10):e0164370. PubMed ID: 27741277
[TBL] [Abstract][Full Text] [Related]
22. Cytogenetic evaluation of mesenchymal stem/stromal cells from patients with myelodysplastic syndromes at different time-points during ex vivo expansion.
Kouvidi E; Stratigi A; Batsali A; Mavroudi I; Mastrodemou S; Ximeri M; Papadaki HA; Pontikoglou CG
Leuk Res; 2016 Apr; 43():24-32. PubMed ID: 26930455
[TBL] [Abstract][Full Text] [Related]
23. Performance comparison of two next-generation sequencing panels to detect actionable mutations in cell-free DNA in cancer patients.
Macías M; Cañada-Higueras E; Alegre E; Bielsa A; Gracia J; Patiño-García A; Ferrer-Costa R; Sendino T; Andueza MP; Mateos B; Rodríguez J; Corral J; Gúrpide A; Lopez-Picazo JM; Perez-Gracia JL; Gil-Bazo I; Alkorta-Aranburu G; González Á
Clin Chem Lab Med; 2020 Jul; 58(8):1341-1348. PubMed ID: 32623849
[TBL] [Abstract][Full Text] [Related]
24. [Diagnosis and prognosis in myelodysplastic syndromes. The impact of cytogenetics].
Mecucci C
Recenti Prog Med; 2014 Mar; 105(3):110-4. PubMed ID: 24675452
[TBL] [Abstract][Full Text] [Related]
25. Hidden chromosome 8 abnormalities detected by FISH in adult primary myelodysplastic syndromes.
Panani AD; Pappa V
In Vivo; 2005; 19(6):979-81. PubMed ID: 16277010
[TBL] [Abstract][Full Text] [Related]
26. [Cytogenetics of myelodysplastic syndromes and its impact as prognostic factor].
Borjas-Gutiérrez C; Domínguez-Cruz MD; González-García JR
Rev Med Inst Mex Seguro Soc; 2017; 55(4):481-489. PubMed ID: 28591503
[TBL] [Abstract][Full Text] [Related]
27. [Karyotype studies of patients with a myelodysplastic syndrome].
Salamanchuk ZIa; Masliak ZV; Lozyns'ka MR; Vyhovs'ka IaI; Lohins'kyĭ VIe; Male P
Tsitol Genet; 1998; 32(1):43-8. PubMed ID: 9695251
[TBL] [Abstract][Full Text] [Related]
28. [Study on phenotypic and cytogenetic characteristics of bone marrow mesenchymal stem cells in myelodysplastic syndromes].
Song LX; Guo J; He Q; Yang LP; Gu SC; Zhang Z; Zhang X; Wu LY; Li X; Chang CK
Zhonghua Xue Ye Xue Za Zhi; 2013 Feb; 34(2):127-32. PubMed ID: 23611219
[TBL] [Abstract][Full Text] [Related]
29. Standardized fluorescence in situ hybridization testing based on an appropriate panel of probes more effectively identifies common cytogenetic abnormalities in myelodysplastic syndromes than conventional cytogenetic analysis: a multicenter prospective study of 2302 patients in China.
Lai YY; Huang XJ; Li J; Zou P; Xu ZF; Sun H; Shao ZH; Zhou DB; Chen FP; Liu ZG; Zhu HL; Wu DP; Wang C; Zhang Y; Li Y; Hou M; Du X; Wang X; Li W; Lai YR; Zhou J; Zhou YH; Fang MY; Qiu L; Wang XM; Zhang GS; Jiang M; Liang YM; Zhang LS; Chen XQ; Bai H; Lin JY
Leuk Res; 2015 May; 39(5):530-5. PubMed ID: 25823643
[TBL] [Abstract][Full Text] [Related]
30. Cytogenetic and Southern blot analysis to demonstrate clonality and to estimate prognosis in patients with myelodysplastic syndromes.
Schmetzer HM; Poleck B; Duell T; Gerhartz HH; Mittermüller J
Ann Hematol; 2000 Jan; 79(1):20-9. PubMed ID: 10663617
[TBL] [Abstract][Full Text] [Related]
31. Clinical Utility of Targeted Next-Generation Sequencing Assay to Detect Copy Number Variants Associated with Myelodysplastic Syndrome in Myeloid Malignancies.
Jiang L; Pallavajjala A; Huang J; Haley L; Morsberger L; Stinnett V; Hardy M; Park R; Ament C; Finch A; Shane A; Parish R; Nozari A; Long P; Adams E; Smith K; Parimi V; Dougaparsad S; Long L; Gocke CD; Zou YS
J Mol Diagn; 2021 Apr; 23(4):467-483. PubMed ID: 33577993
[TBL] [Abstract][Full Text] [Related]
32. Recurrent Cytogenetic Abnormalities in Myelodysplastic Syndromes.
Wall M
Methods Mol Biol; 2017; 1541():209-222. PubMed ID: 27910026
[TBL] [Abstract][Full Text] [Related]
33. Autologous peripheral blood stem cell transplantation in acute myeloblastic leukaemia and myelodysplastic syndrome patients: evaluation of tumour cell contamination of leukaphereses by cytogenetic and molecular methods.
Testoni N; Lemoli RM; Martinelli G; Carboni C; Pelliconi S; Ottaviani E; Ruggeri D; Rizzi S; Motta MR; Visani G; Tura S
Bone Marrow Transplant; 1998 Dec; 22(11):1065-70. PubMed ID: 9877268
[TBL] [Abstract][Full Text] [Related]
34. Fluorescence in situ hybridization improves the detection of 5q31 deletion in myelodysplastic syndromes without cytogenetic evidence of 5q-.
Mallo M; Arenillas L; Espinet B; Salido M; Hernández JM; Lumbreras E; del Rey M; Arranz E; Ramiro S; Font P; González O; Renedo M; Cervera J; Such E; Sanz GF; Luño E; Sanzo C; González M; Calasanz MJ; Mayans J; García-Ballesteros C; Amigo V; Collado R; Oliver I; Carbonell F; Bureo E; Insunza A; Yañez L; Muruzabal MJ; Gómez-Beltrán E; Andreu R; León P; Gómez V; Sanz A; Casasola N; Moreno E; Alegre A; Martín ML; Pedro C; Serrano S; Florensa L; Solé F
Haematologica; 2008 Jul; 93(7):1001-8. PubMed ID: 18591625
[TBL] [Abstract][Full Text] [Related]
35. Treatment of Non-Small-Cell Lung Cancer Based on Circulating Cell-Free DNA and Impact of Variation Allele Frequency.
Bustamante Alvarez JG; Janse S; Owen DH; Kiourtsis S; Bertino EM; He K; Carbone DP; Otterson GA
Clin Lung Cancer; 2021 Jul; 22(4):e519-e527. PubMed ID: 33414052
[TBL] [Abstract][Full Text] [Related]
36. Molecular definition of chromosome arm 5q deletion end points and detection of hidden aberrations in patients with myelodysplastic syndromes and isolated del(5q) using oligonucleotide array CGH.
Evers C; Beier M; Poelitz A; Hildebrandt B; Servan K; Drechsler M; Germing U; Royer HD; Royer-Pokora B
Genes Chromosomes Cancer; 2007 Dec; 46(12):1119-28. PubMed ID: 17823930
[TBL] [Abstract][Full Text] [Related]
37. Cytogenetic aspects of adult primary myelodysplastic syndromes: clinical implications.
Panani AD; Roussos C
Cancer Lett; 2006 Apr; 235(2):177-90. PubMed ID: 15935553
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of the utility of peripheral blood vs bone marrow in karyotype and fluorescence in situ hybridization for myelodysplastic syndrome diagnosis.
Asadi Fakhr Z; Mehrzad V; Izaditabar A; Salehi M
J Clin Lab Anal; 2018 Nov; 32(9):e22586. PubMed ID: 29893006
[TBL] [Abstract][Full Text] [Related]
39. Identification of novel cytogenetic markers with prognostic significance in a series of 968 patients with primary myelodysplastic syndromes.
Solé F; Luño E; Sanzo C; Espinet B; Sanz GF; Cervera J; Calasanz MJ; Cigudosa JC; Millà F; Ribera JM; Bureo E; Marquez ML; Arranz E; Florensa L
Haematologica; 2005 Sep; 90(9):1168-78. PubMed ID: 16154839
[TBL] [Abstract][Full Text] [Related]
40. Targeted re-sequencing analysis of 25 genes commonly mutated in myeloid disorders in del(5q) myelodysplastic syndromes.
Fernandez-Mercado M; Burns A; Pellagatti A; Giagounidis A; Germing U; Agirre X; Prosper F; Aul C; Killick S; Wainscoat JS; Schuh A; Boultwood J
Haematologica; 2013 Dec; 98(12):1856-64. PubMed ID: 23831921
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
